Corey Michael Watton insider trades: Zevra Therapeutics (ZVRA) stock buys and sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Corey reports to the SEC
Open-market buys and sales
6 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Aug 10, 2026 | ZVRA | ↓ Sell | 12,300 | $11.25 | $138K | Direct | Aug 12, 2026 (2d) |
| Mar 28, 2025 | ZVRA | ↑ Buy | 300 | $7.84 | $2K | Direct | Mar 31, 2025 (3d) |
| Oct 11, 2024 | ZVRA | ↑ Buy | 500 | $7.92 | $4K | Direct | Oct 16, 2024 (5d) |
| Jun 23, 2023 | ZVRA | ↑ Buy | 275 | $5.95 | $2K | Direct | Jun 26, 2023 (3d) |
| Jun 9, 2023 | ZVRA | ↑ Buy | 325 | $5.52 | $2K | Direct | Jun 13, 2023 (4d) |
| May 30, 2023 | ZVRA | ↑ Buy | 400 | $5.11 | $2K | Direct | May 31, 2023 (1d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other ZVRA insiders
Open-market trades in the last 12 months
About Corey Michael Watton's insider trades
Corey Michael Watton is a director at Zevra Therapeutics (ZVRA). Since May 30, 2023, Corey has reported 5 open-market purchases worth $12K and 1 sale worth $138K on SEC Form 4. In the last 12 months: 1 sale ($138K).
Their filings also include grants and awards (4 filings), option exercises (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every ZVRA insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.